Allakos Inc

About

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.

Growth

Allakos is a biopharmaceutical company that is in the scale-up stage of growth. The company has shown significant progress in advancing its lead therapeutic antibody, AK006, targeting Siglec-6 receptors expressed on mast cells. With a focus on developing therapeutics for allergy, inflammatory, and proliferative diseases, Allakos is poised for further expansion in the biopharmaceutical market.

Achievements

Allakos has achieved key milestones in its history, including the successful development of the novel therapeutic antibody AK006 targeting Siglec-6 receptors on mast cells. The company has shown promising results in preclinical studies and is currently progressing towards Phase 1 clinical trials, with a focus on Chronic Spontaneous Urticaria. These achievements mark significant progress for Allakos in the field of immunomodulatory therapies.

Case Studies

Allakos has been involved in notable case studies related to the development of AK006 and its potential indications in inflammation and immunology. The company's research and clinical trials have demonstrated the efficacy of targeting Siglec-6 receptors on mast cells in treating conditions such as Chronic Spontaneous Urticaria. These case studies highlight the impact of Allakos' therapeutic approach on patient outcomes and disease management.

Socials

company logo
CEO
Founded

-

Operating Status

Active

Industry

Health Care/Life Sciences

headquarters
Address

825 Industrial Road Suite 500 San Carlos California 94070 United States...

Country

United States

Employees

131

Key People

Dolca Thomas (Director)

Amy L. Ladd (Director)

Harlan Baird Radford (Chief Financial Officer)

Chin Lee (Chief Medical Officer)

Revenue

-

Operating Income

Stock Price

$0.8533


Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success

Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.

Why Choose a VDC for Your Company?

1. Cost Optimization:

Save up to 70% on operational costs by leveraging remote teams and streamlined processes.

2. Expert Access:

Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.

3. Scalable Teams:

Scale your team as business needs evolve, from initial project setup to long-term support.

4. Accelerated Timelines:

Leverage 24/7 global teams to reduce project delays and speed up implementation.

5. Continuous Support:

Ensure uninterrupted business performance with ongoing maintenance and updates.

Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us

Book A Meeting To Setup Your VDCovertime

Welcome to AiDOOS Wiki

AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.


Allakos Inc

company logo

About Allakos Inc

Allakos, Inc. engages in the development of therapeutic antibodies. Its primary product is AK002, a monoclonal antibody used for the treatment of various eosinophil and mast cell related diseases such as eosinophilic gastritis, urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis. The company was founded by Christopher Bebbington, Nenad Tomasevic, Bruce S. Bochner, and Robert Schleimer in 2012 and is headquartered in San Carlos, CA.


Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success

Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.

Why Choose a VDC for Your Company?

1. Cost Optimization:

Save up to 70% on operational costs by leveraging remote teams and streamlined processes.

2. Expert Access:

Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.

3. Scalable Teams:

Scale your team as business needs evolve, from initial project setup to long-term support.

4. Accelerated Timelines:

Leverage 24/7 global teams to reduce project delays and speed up implementation.

5. Continuous Support:

Ensure uninterrupted business performance with ongoing maintenance and updates.

Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us

Book A Meeting To Setup Your VDCovertime
overtime